|Articles|April 1, 2004

April 2004
Volume 10
Issue 4

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

Author(s)Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD, Brenda Motheral, PhD, Doug Mager, BS

Articles in this issue

over 22 years ago

Article

Improving Cancer Screening Adherence: Using the "Teachable Moment" as a Delivery Setting for Educational Interventions

over 22 years ago

Article

Population-Based Hepatitis C Surveillance and Treatment in a National Managed Care Organization

over 22 years ago

Article

Malpractice Prevention, Patient Safety, and Quality of Care: A Critical Linkage

over 22 years ago

Article

Comparing Breast Cancer Case Identification Using HMO Computerized Diagnostic Data and SEER Data

over 22 years ago

Article

Health Plan Policies and Programs for Colorectal Cancer Screening: A National Profile

over 22 years ago

Article

Primary Care Practice and Facility Quality Orientation: Influence on Breast and Cervical Cancer Screening Rates

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Woman getting her eyes checked | Image credit: N F/peopleimages.com - stock.adobe.com

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

ByStella Ko, PharmD, MS,David Tabano, PhD,Mona Kilany, PhD,Kimberly Jinnett, PhD, MSPH,Victor Kirksey, PhD,Reg Ledesma, MS,Sarah Mossburg, PhD,Charlene Nguyen, MPP, BSc,Bryan A. Wilson, PhD, MBA

September 15th 2026

Doctor talking with patient | Image credit: Prostock-studio - stock.adobe.com

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

ByAayush Sisodia, MSHI, BDS

September 15th 2026

Man with chest pain | Image credit: Liubomir - stock.adobe.com

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

ByHector P. Rodriguez, PhD, MPH, Hattie R. Hanley, MPP,Stephen M. Shortell, PhD, MBA, MPH

September 15th 2026

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

Articles in this issue

Related Content

Understanding Barriers to Diabetic Eye Care for Alabama’s Underserved Patients

Teach-Back Is Essential Care Infrastructure: A Low-Cost Strategy for Safer, More Equitable Care

The Right Care Initiative: Promoting Accountable Care to Prevent Cardiovascular Death

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD

5 Things to Know About the 2026 ESC Heart Failure Guidelines

Enlicitide, Oral PCSK9 Inhibitor, Cuts LDL 60% in CORALreef Trials

FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care